These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15683066)

  • 1. Access to essential drugs in 11 Brazilian cities: a community-based evaluation and action method.
    Karnikowski MG; Nóbrega OT; Naves JO; Silver LD
    J Public Health Policy; 2004; 25(3-4):288-98. PubMed ID: 15683066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The essential drugs program in Haiti].
    Benitez AJ
    Sante Publique; 1998 Dec; 10(4):401-12. PubMed ID: 10065006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off?
    Carasso BS; Lagarde M; Tesfaye A; Palmer N
    Trop Med Int Health; 2009 Nov; 14(11):1394-400. PubMed ID: 19754520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential drugs in the Gambia.
    Jallow MT
    World Health Forum; 1993; 14(2):136-9. PubMed ID: 8185753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-five years of essential medicines.
    Quick JD; Hogerzeil HV; Velasquez G; Rago L
    Bull World Health Organ; 2002; 80(11):913-4. PubMed ID: 12481216
    [No Abstract]   [Full Text] [Related]  

  • 7. Measuring the quality of child health care at first-level facilities.
    Gouws E; Bryce J; Pariyo G; Armstrong Schellenberg J; Amaral J; Habicht JP
    Soc Sci Med; 2005 Aug; 61(3):613-25. PubMed ID: 15899320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Essential medicines and access to primary health care in the medical district of Mambéré-Kadéï].
    Mouala C; Abeye J; Goumba A
    Sante; 2009; 19(4):175-9. PubMed ID: 20172844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug supply strategies, constraints and prospects in Nigeria.
    Yusuff KB; Tayo F
    Afr J Med Med Sci; 2004 Dec; 33(4):389-94. PubMed ID: 15977451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of pharmacy interventions in improving availability of essential medicines at the primary healthcare level.
    Nunan M; Duke T
    Trop Med Int Health; 2011 May; 16(5):647-58. PubMed ID: 21342375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of pharmaceutical assistance in public primary care in Brasilia, Brazil].
    Naves Jde O; Silver LD
    Rev Saude Publica; 2005 Apr; 39(2):223-30. PubMed ID: 15895142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of university technology transfer operations in assuring access to medicines and vaccines in developing countries.
    Nelsen L
    Yale J Health Policy Law Ethics; 2003; 3(2):301-8. PubMed ID: 14577146
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care.
    De Lima L; Krakauer EL; Lorenz K; Praill D; Macdonald N; Doyle D
    J Pain Symptom Manage; 2007 May; 33(5):521-6. PubMed ID: 17482041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organizations for health care reform.
    Health PAC Bull; 1993; 23(1):46-7. PubMed ID: 10126183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumers' healthcare rights in Brazil.
    Schmidt MJ
    Int Nurs Rev; 1996; 43(5):139-41. PubMed ID: 8894838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Availability of essential medications at primary level units of the Health Department of Tamaulipas, Mexico].
    Reséndez C; Garrido F; Gómez-Dantés O
    Salud Publica Mex; 2000; 42(4):298-308. PubMed ID: 11026071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The essential drugs in Tanzania: a ten year (1979-1988) review following the Alma Ata declaration.
    Kasilo OJ; Mwaluko GM
    East Afr Med J; 1992 May; 69(5):288-93. PubMed ID: 1644050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran.
    Cheraghali AM; Nikfar S; Behmanesh Y; Rahimi V; Habibipour F; Tirdad R; Asadi A; Bahrami A
    East Mediterr Health J; 2004 May; 10(3):406-15. PubMed ID: 16212218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.